TY - JOUR
T1 - Hépatite fulminante à virus Epstein-Barr
T2 - Évolution favorable après transplantation hépatique
AU - Dumortier, Jérôme
AU - Mekki, Yahia
AU - Rimmelé, Thomas
AU - Ber, Charles
AU - Maillard, Emmanuel
AU - Fafi-Kremer, Samira
AU - Lina, Bruno
AU - Scoazec, Jean Yves
AU - Delafosse, Bertrand
AU - Boillot, Olivier
PY - 2007/1/1
Y1 - 2007/1/1
N2 - Viral hepatitis are the leading cause of fulminant hepatitis. Epstein Barr virus is the viral agent involved in infectious mononucleosis, associated with a frequent and usually benign hepatitis, except in case of immunodeficiency, congenital or acquired. We report the case of an immunocompetent young woman who presented an EBV induced fulminant hepatic failure, requiring liver transplantation that was successful. This observation emphasizes that EBV must be known as a posssible cause of fulminant hepatitis and that liver transplantation is probably the unique therapeutic option to avoid a usually fatal course.
AB - Viral hepatitis are the leading cause of fulminant hepatitis. Epstein Barr virus is the viral agent involved in infectious mononucleosis, associated with a frequent and usually benign hepatitis, except in case of immunodeficiency, congenital or acquired. We report the case of an immunocompetent young woman who presented an EBV induced fulminant hepatic failure, requiring liver transplantation that was successful. This observation emphasizes that EBV must be known as a posssible cause of fulminant hepatitis and that liver transplantation is probably the unique therapeutic option to avoid a usually fatal course.
UR - http://www.scopus.com/inward/record.url?scp=34948841448&partnerID=8YFLogxK
U2 - 10.1016/S0399-8320(07)91934-X
DO - 10.1016/S0399-8320(07)91934-X
M3 - Article
C2 - 17925776
AN - SCOPUS:34948841448
SN - 0399-8320
VL - 31
SP - 725
EP - 728
JO - Gastroenterologie Clinique et Biologique
JF - Gastroenterologie Clinique et Biologique
IS - 8-9 C1
ER -